|
|
Advertisement |
 |
|
|
|
Industry update |
//EY (London, UK) appointed Pamela Spence to the role of Global Life Sciences Industry Leader to its global life sciences sector practice.//F2G Ltd (Manchester, UK) appointed Ralf Schmid as Chief Financial Officer.//Chronos Therapeutics Ltd (Oxford, UK)appointed Dr. Fraser Murray and Dr. Timothy Schulz-Utermoehl as Vice Presidents of Pre-Clinical Development.// |
|
|
|
|